Thermo Fisher Scientific (TMO) – Research Analysts’ Weekly Ratings Changes

A number of research firms have changed their ratings and price targets for Thermo Fisher Scientific (NYSE: TMO):

• 9/9/2026 – Thermo Fisher Scientific is now covered by Piper Sandler. They set an “overweight” rating on the stock.
• 9/9/2026 – Thermo Fisher Scientific is now covered by Scotiabank. They set an “outperform” rating on the stock.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by BMO Capital Markets to “market perform”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Wells Fargo & Company from “overweight” to “underweight”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Citigroup Inc. from “buy” to “underperform”.
• 9/9/2026 – Thermo Fisher Scientific was downgraded by Deutsche Bank Aktiengesellschaft from “buy” to “hold”.
• 9/8/2026 – Thermo Fisher Scientific was upgraded by UBS Group AG from “neutral” to “buy”. They now have a $730.00 price target on the stock, up from $540.00.
• 9/3/2026 – Thermo Fisher Scientific is now covered by CLSA. They set an “outperform” rating and a C$748.00 price target on the stock.
• 9/3/2026 – Thermo Fisher Scientific is now covered by CLSA. They set a “moderate buy” rating and a C$748.00 price target on the stock.
• 9/1/2026 – Thermo Fisher Scientific was upgraded by HSBC Holdings plc from “hold” to “strong-buy”.
• 8/28/2026 – Thermo Fisher Scientific was upgraded by Weiss Ratings from “hold (c)” to “hold (c+)”.
• 8/5/2026 – Thermo Fisher Scientific was given a new $650.00 price target by Stifel Nicolaus.
• 8/1/2026 – Thermo Fisher Scientific was upgraded by Wall Street Zen from “hold” to “buy”.
• 7/27/2026 – Thermo Fisher Scientific had its price target raised by Piper Sandler from $510.00 to $600.00. They now have a “neutral” rating on the stock.
• 7/24/2026 – Thermo Fisher Scientific had its price target raised by Morgan Stanley from $620.00 to $650.00. They now have an “overweight” rating on the stock.
• 7/24/2026 – Thermo Fisher Scientific had its price target raised by Royal Bank Of Canada from $490.00 to $580.00. They now have a “sector perform” rating on the stock.
• 7/24/2026 – Thermo Fisher Scientific had its price target raised by Barclays PLC from $625.00 to $650.00. They now have an “overweight” rating on the stock.
• 7/23/2026 – Thermo Fisher Scientific had its “buy” rating reaffirmed by Jefferies Financial Group Inc.. They now have a $630.00 price target on the stock.
• 7/14/2026 – Thermo Fisher Scientific was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.

Thermo Fisher Scientific Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Tuesday, September 15th will be paid a dividend of $0.47 per share. This represents a $1.88 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date is Tuesday, September 15th. Thermo Fisher Scientific’s dividend payout ratio is presently 10.11%.

Insider Buying and Selling

In other Thermo Fisher Scientific news, CAO Joseph R. Holmes sold 420 shares of the company’s stock in a transaction on Friday, August 7th. The stock was sold at an average price of $584.81, for a total transaction of $245,620.20. Following the completion of the sale, the chief accounting officer directly owned 2,966 shares in the company, valued at $1,734,546.46. This represents a 12.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Marc N. Casper sold 10,000 shares of the firm’s stock in a transaction on Thursday, August 20th. The shares were sold at an average price of $629.27, for a total value of $6,292,700.00. Following the completion of the sale, the chief executive officer directly owned 123,925 shares in the company, valued at approximately $77,982,284.75. This represents a 7.47% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 73,768 shares of company stock worth $44,122,820. 0.33% of the stock is owned by company insiders.

Thermo Fisher Scientific Inc is a global supplier of scientific equipment, laboratory services and analytical technologies. The company serves pharmaceutical and biotechnology companies, clinical laboratories, academic and government institutions, industrial businesses and other research organizations.

Its products and services include laboratory instruments, analytical systems, reagents, consumables, software and related services. Thermo Fisher also provides laboratory supplies and equipment, bioproduction solutions, genetic analysis technologies, clinical diagnostics, specialty diagnostic products and contract research and manufacturing services through its laboratory services businesses.

The company was formed in 2006 through the merger of Thermo Electron Corporation and Fisher Scientific International.